CryoLife, Inc. (NYSE:CRY) manufactures, processes, and distributes medical devices and implantable living tissues used in cardiac and vascular surgical procedures. From mid-April until early October, the stock has done well, rising over 60%. Since then however, the share price dropped 20% due to a disappointing Q3 earnings report and lowered full-year guidance, resulting at least partially from the negative impact of recent hurricanes. The share price further plummeted after the company announced a $225 million acquisition of JOTEC, German-based, privately-held developer of technologically differentiated endovascular stent grafts.
CRY data by YCharts
Best Medical Stocks To Buy For 2019: ServiceMaster Global Holdings, Inc.(SERV)
Advisors' Opinion:- [By Logan Wallace]
Xact Kapitalforvaltning AB raised its stake in Servicemaster Global Holdings Inc (NYSE:SERV) by 33.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,711 shares of the business services provider’s stock after acquiring an additional 3,900 shares during the period. Xact Kapitalforvaltning AB’s holdings in Servicemaster Global were worth $799,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
- [By Rich Smith]
The clock reads 11:45 AM EDT, and shares of ServiceMaster Global Holdings (NYSE:SERV) are either down 34% or maybe down less than 2%, depending on whom you ask. Google Finance says the former, while Yahoo! Finance reports the latter.
- [By Max Byerly]
ServiceMaster (NYSE:SERV)’s share price reached a new 52-week high and low during trading on Tuesday . The company traded as low as $55.63 and last traded at $54.76, with a volume of 207508 shares traded. The stock had previously closed at $55.35.
Best Medical Stocks To Buy For 2019: Arthur J. Gallagher & Co.(AJG)
Advisors' Opinion:- [By Motley Fool Transcribing]
Arthur J. Gallagher & Co. (NYSE:AJG) Q4 2018 Earnings Conference CallJan. 31, 2019 5:15 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Arthur J Gallagher & Co (AJG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
HRT Financial LLC acquired a new stake in shares of Arthur J Gallagher & Co (NYSE:AJG) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 3,197 shares of the financial services provider’s stock, valued at approximately $208,000.
- [By Max Byerly]
US Bancorp DE boosted its holdings in Arthur J Gallagher & Co (NYSE:AJG) by 404.6% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 417,551 shares of the financial services provider’s stock after buying an additional 334,800 shares during the quarter. US Bancorp DE’s holdings in Arthur J Gallagher & Co were worth $27,259,000 at the end of the most recent reporting period.
Best Medical Stocks To Buy For 2019: Navios Maritime Partners LP(NMM)
Advisors' Opinion:- [By Ethan Ryder]
Get a free copy of the Zacks research report on Navios Maritime Partners (NMM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Navios Maritime Partners (NMM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Best Medical Stocks To Buy For 2019: ARMOUR Residential REIT, Inc.(ARR)
Advisors' Opinion:- [By Max Byerly]
ARMOUR Residential REIT, Inc. (NYSE:ARR) declared a monthly dividend on Wednesday, May 30th, Wall Street Journal reports. Stockholders of record on Friday, June 15th will be paid a dividend of 0.19 per share by the real estate investment trust on Thursday, June 28th. This represents a $2.28 annualized dividend and a dividend yield of 9.72%. The ex-dividend date is Thursday, June 14th.
- [By Shane Hupp]
IndexIQ Advisors LLC trimmed its stake in ARMOUR Residential REIT, Inc. (NYSE:ARR) by 6.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,484 shares of the real estate investment trust’s stock after selling 2,444 shares during the period. IndexIQ Advisors LLC owned approximately 0.09% of ARMOUR Residential REIT worth $855,000 as of its most recent SEC filing.
- [By Shane Hupp]
Wells Fargo & Company MN decreased its position in shares of ARMOUR Residential REIT, Inc. (NYSE:ARR) by 19.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 201,989 shares of the real estate investment trust’s stock after selling 50,292 shares during the period. Wells Fargo & Company MN owned about 0.48% of ARMOUR Residential REIT worth $4,703,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Joseph Griffin]
ARMOUR Residential REIT (NYSE:ARR) was the target of some unusual options trading activity on Thursday. Stock traders acquired 657 call options on the stock. This represents an increase of approximately 1,163% compared to the typical volume of 52 call options.
Best Medical Stocks To Buy For 2019: NV5 Global, Inc.(NVEE)
Advisors' Opinion:- [By Jason Hall]
NV5's (NASDAQ:NVEE) stock has been up and down and all around since being recommended, but the company still looks to be in a fantastic long-term position. Pattern Energy's (NASDAQ:PEGI) stock has been a bit worse for wear, as the tax code has presented some new and significant challenges. But Pattern's story doesn't end there, and there's plenty of bright spots for the business. Tune in to find out how rec-worthy these companies are today and what investors need to know about them before buying.
- [By Neha Chamaria, Jason Hall, and Dan Caplinger]
So we asked three Motley Fool contributors to identify a stock they believe could be potential multibaggers that could put even Shopify's returns to shame. Here's why they chose NV5 Global Inc. (NASDAQ:NVEE), Raven Industries (NASDAQ:RAVN), and Square Inc. (NYSE:SQ).
- [By Shane Hupp]
NV5 Global (NASDAQ:NVEE) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Thursday.
- [By Shane Hupp]
Get a free copy of the Zacks research report on NV5 Global (NVEE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Jason Hall, George Budwell, and Daniel Miller]
But if you're considering penny stocks, then you're probably willing to invest in higher-risk stocks that could generate big returns for patient investors willing to ride out the ups and downs. Three Motley Fool contributors have identified NV5 Global Inc (NASDAQ:NVEE), Crispr Therapeutics AG (NASDAQ:CRSP), and Tesla Inc (NASDAQ:TSLA) as risk-reward stocks well worth considering.
- [By Max Byerly]
Get a free copy of the Zacks research report on NV5 Global (NVEE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment